Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: TAP Pharmaceutical Products
Current Parent Company: Takeda Pharmaceutical
Penalty: $150,000,000
Year: 2005
Date: May 12, 2005
Offense Group: competition-related offenses
Primary Offense: price-fixing or anti-competitive practices
Mega-Scandal: Drug Pricing Abuses
Violation Description: TAP agreed to pay $150 million to settle litigation alleging it conspired with doctors to inflate the average wholesale price for its prostate cancer drug Lupron.
Level of Government: federal
Action Type: private litigation
Court: District of Massachusetts
Civil or Criminal Case: civil
Case ID: 1:01cv10861 MDL 1430
Case Name: Porter v. TAP Pharmaceutical, et al
Private Lawsuit Resolution Type: settlement
HQ Country of Current Parent: Japan
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: 2010 Jury Verdicts LEXIS 25575
Link to PACER Case Docket (must be logged in): (click here)
Link to Archived Court Document:  subscribe to see this data field
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.